Cardiometabolic Risk of Obese Subjects: Cross-sectional Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
experimental study with analysis on tissues. This study aims to study cardiometabolic risk from a genetic, clinical, instrumental and laboratory point of view in a population of subjects with obesity.
• Age > 18 years
BMI > 30 Kg/m2
In primary prevention for cardiovascular disease
Ability to communicate, make themselves understood and adhere to study-specific procedures
Patients already enrolled by the Research Units involved in the enrolment
Glycated hemoglobin level > 55 mmol/L
Patients suffering from obesity secondary to endocrinological diseases or iatrogenic causes
Patients with heterozygous Familial Hypercholesterolemia (Dutch Lipid Score - DLS>8)